ArticleBMC psychiatry2025
Associations of cumulative hearing and vision loss with depression among U.S. adults aged 50 and older: results from the health and retirement study.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHearing or vision loss at a single time point was associated with depression. However, little is known about how cumulative hearing and vision loss contributes to the depression risk. We aimed to examine associations of cumulative hearing loss (CHL), vision loss (CVL), dual sensory loss (CDSL), and any sensory loss (CASL) with the subsequent trajectories of depressive symptoms and risks of incident depression among US adults aged ≥ 50.
methodsA subpopulation was extracted from the Health and Retirement Study (HRS), a nationally representative cohort study. The final sample included 7,545 adults aged 50 and older. Burdens of CHL, CVL, CDSL, and CASL were assessed spanning eight years (1998-2006) across five Waves (Waves 4-8) and were categorized into 0, 1, 2, and ≥ 3 time points. Depressive symptoms were measured by the Center for Epidemiologic Studies Depression Scale (CES-D) during a ten-year follow-up from Wave 9 (2008) to Wave 15 (2020). Mixed-effects linear regression models were used to estimate associations between CVL and changes in depressive symptoms over time (CES-D scores), incorporating CVL × time interactions to assess differential rates of change. Cox proportional hazard regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between CVL and the risk of incident depression. Models were adjusted for sociodemographic factors (Model 1) and additionally for lifestyle and health-related covariates (Model 2). Similarly, we separately analyzed associations of CHL, CBSL, and CASL with trajectories of depressive symptoms and risks of incident depression.
resultsTwo thousand four hundred twenty-one participants developed an incident depression over a median follow-up of eight years. Results indicated that compared with participants without vision loss, those with CVL at 1, 2, and ≥ 3 time points during Waves 4-8 had significantly higher CES-D scores and higher risks of incident depression during Waves 9-15. Similar positive associations were found for CHL, CDSL, and CASL.
conclusionsHeavier burdens of CHL, CVL, CDSL, and CASL were associated with accelerated increases in depressive symptoms and elevated risks of incident depression among US adults aged 50 and older.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.